Healthpeak PropertiesDOC +1.51%74 Peter Lynch Fair Value is $1.43 as of Jun. 27, 2026, which is 88% below its 10-year median of 11.49. GuruFocus rates DOC with a GF Score™ of 74/100 and a GF Value™ of $19.56 (Fairly Valued). The stock has 10 warning signs investors should review. Among 167 REITs companies, Healthpeak Properties ranks worse than 98.2% on this metric.
Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.
Here, as of today, Healthpeak Properties's PEG is 1. Healthpeak Properties's 5-Year TTM EBITDA Growth Rate is 6.61.
Healthpeak Properties's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was $0.22. Therefore, the Peter Lynch Fair Value for today is $1.43.
The historical rank and industry rank for Healthpeak Properties's Peter Lynch Fair Value or its related term are showing as below:
DOC'
s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 8.97 Med: 11.49 Max: 67
Current: 15.07
During the past 13 years, the highest Price to Peter Lynch Fair Value Ratio of Healthpeak Properties was 67.00. The lowest was 8.97. And the median was 11.49.
DOC's Price-to-Peter-Lynch-Fair-Value is ranked worse than 98.2% of 167
companies
in the REITs industry
Industry Median: 1.16
vs DOC: 15.07
Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.
Healthpeak Properties (NYSE:DOC) Peter Lynch Fair Value Explanation
Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.
Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.
Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 6.61 instead of 15 in this case.
Healthpeak Properties's Price to Peter Lynch Fair Value Ratio for today is calculated as
Price to Peter Lynch Fair Value
=
Share Price
/
Peter Lynch Fair Value
=
21.55
/
1.43
=
15.02
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Healthpeak Properties Peter Lynch Fair Value Related Terms
Healthpeak Properties Peter Lynch Fair Value Historical Data
* Premium members only.
The historical data trend for Healthpeak Properties's Peter Lynch Fair Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Healthpeak Properties Peter Lynch Fair Value Chart
DOC vs OHI, AHR, CTRE: Peter Lynch Fair Value Comparison
For the REIT - Healthcare Facilities subindustry, Healthpeak Properties's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Healthpeak Properties Price-to-Peter-Lynch-Fair-Value vs REITs Industry
For the REITs industry and Real Estate sector, Healthpeak Properties's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:
* The bar in red indicates where Healthpeak Properties's Price-to-Peter-Lynch-Fair-Value falls into.
Healthpeak Properties's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.22.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.
If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.
If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.
Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.
Healthpeak Properties (DOC) has a Peter Lynch Fair Value of $1.43 as of Jun. 27, 2026. Peter Lynch Fair Value is the stock value based on a company's current earnings and five-year earnings growth, assuming a PEG of one. View historical data on Healthpeak Properties and its competitors. This is 88% below median its historical median of 11.49. Over the past decade, Healthpeak Properties' Peter Lynch Fair Value has ranged from 8.97 to 67.00. According to the industry distribution chart, Healthpeak Properties ranks #164 out of 167 companies in the REITs industry, placing it in the top 98.2%.
Is Healthpeak Properties' Peter Lynch Fair Value too high?
Healthpeak Properties' current Peter Lynch Fair Value of $1.43 is 88% below median its 10-year median of 11.49. Over the past 10 years, this metric has ranged from a low of 8.97 to a high of 67.00. The REITs industry median Peter Lynch Fair Value is 1.16. Healthpeak Properties' value of $1.43 is 23.3% above this industry median. Based on the distribution chart, Healthpeak Properties ranks #164 out of 167 companies in the REITs industry, which is in the bottom quartile relative to peers. Overall, Healthpeak Properties has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Healthpeak Properties' Peter Lynch Fair Value compare to OHI and AHR?
According to the REITs industry distribution chart, Healthpeak Properties ranks #164 out of 167 companies for Peter Lynch Fair Value. This places Healthpeak Properties in the lower half of its industry. The industry median Peter Lynch Fair Value is 1.16. Healthpeak Properties' value of $1.43 is 23.3% above this benchmark. Historically, Healthpeak Properties' own Peter Lynch Fair Value has ranged from 8.97 to 67.00 over the past decade. While the company's 10-year median is 11.49 vs. the industry median of 1.16, Healthpeak Properties has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Peter Lynch Fair Value for a REITs company?
The median Peter Lynch Fair Value among REITs companies is 1.16, based on 167 companies in the industry. Companies in the top quartile (top 25%) have a Peter Lynch Fair Value significantly above this median, while those in the bottom quartile fall well below. However, Peter Lynch Fair Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Healthpeak Properties's current Peter Lynch Fair Value of $1.43 is 23.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Peter Lynch Fair Value mean?
A high Peter Lynch Fair Value can signal that a stock is expensive relative to its fundamentals. Peter Lynch Fair Value is the stock value based on a company's current earnings and five-year earnings growth, assuming a PEG of one. View historical data on Healthpeak Properties and its competitors. For the REITs industry, the median Peter Lynch Fair Value is 1.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Healthpeak Properties's current Peter Lynch Fair Value is $1.43, which is 88% below median its own 10-year median of 11.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Healthpeak Properties stock overvalued right now?
Based on GuruFocus' analysis, Healthpeak Properties (DOC) is currently considered Fairly Valued. The stock's GF Value™ is $19.56, compared to a current price of $21.55 — trading 10.2% above its estimated fair value. The current Peter Lynch Fair Value is $1.43, which is 88% below median its 10-year median of 11.49 and 23.3% above the REITs industry median of 1.16. Healthpeak Properties' overall GF Score™ is 74/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Peter Lynch Fair Value calculated?
Peter Lynch Fair Value is calculated from a company's financial statements. For Healthpeak Properties (DOC), the current Peter Lynch Fair Value is $1.43 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Healthpeak Properties (DOC) Overvalued in 2026?
Based on GuruFocus' analysis, Healthpeak Properties stock appears to be overvalued.
The current stock price of $21.55 is trading 10.2% above its estimated GF Value™ of $19.56.
GuruFocus considers Healthpeak Properties to be Fairly Valued.
Key valuation signals for DOC:
Peter Lynch Fair Value: $1.43 (88% below median its 10-year median of 11.49)
GF Value™: $19.56 vs. price of $21.55 (10.2% above fair value)
Industry Position: 23.3% above the REITs median (#164 of 167)
No single metric tells the full story. See the DOC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Healthpeak owns a diversified healthcare portfolio of approximately 700 in-place properties spread across mainly medical office and life science assets, plus a handful of senior housing, hospital, and skilled nursing/post-acute care assets, as well.
74GF Score
Get the complete analysis for DOC
Peter Lynch Fair Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DOC has been successfully added to your 
